Login to Your Account



Leg Up For Avastin?

ImClone's Phase III Erbitux Trial In NSCLC Fails To Hit Endpoint

By Randall Osborne


Friday, July 13, 2007
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription